Baidu
map

Cytokine release syndrome and relevant factors of CD19 targeted chimeric antigen receptor T cell therapy in relapsed/refractory B cell hematological malignancies

Xu, QW; Xu, H; Xue, L; Wang, L; Zhang, XH; Yao, W; Wan, X; Tong, J; Liu, HL; Liu, X; Zhu, XY; Sun, ZM; Wang, XB

Wang, XB (通讯作者),First Affiliated Hosp USTC, Dept Hematol, 17 Lujiang Rd, Hefei, Anhui, Peoples R China.

TRANSFUSION AND APHERESIS SCIENCE, 2022; 61 (6):

Abstract

Objectives and methods: We reviewed the outcomes of 77 episodes of CD19 CAR-T therapy in 67 patients with B cell hematological malignancies from Octob......

Full Text Link


Baidu
map
Baidu
map
Baidu
map